tirzepatide judge ruling Lilly Takes Four Compounders to Court for Allegedly Producing Knockoff FDA Can Keep Tirzepatide off

This means the compounded version has not gone through the same rigorous FDA review process

The legal barrage comes months after the FDA in December 2024 affirmed that tirzepatide is no longer in shortage and formally barred compounders, who had legally been allowed to make the drug while it was in shortage, from producing and distributing knockoff versions, giving them until March 19 to comply

Why tirzepatide and semaglutide arent magic jabs for weight loss Like other drugs in the GLP-1 family, Ozempic and Mounjaro are medications that make it easier to lose weight and stick to healthy habitsbut they don't produce weight loss on their own

This specific ratio matters because underfilling or overfilling alters dose accuracy and can affect injection experience

This allows 503A and 503B compounding pharmacies to produce patient-specific or batch-compounded versions

A majority of the reported events occurred in patients who had experienced nausea, vomiting, diarrhea, or dehydration